Skip to Content

Khedezla Side Effects

Generic Name: desvenlafaxine

Note: This document contains side effect information about desvenlafaxine. Some of the dosage forms listed on this page may not apply to the brand name Khedezla.

In Summary

Common side effects of Khedezla include: constipation, dizziness, drowsiness, insomnia, nausea, decreased appetite, hyperhidrosis, and xerostomia. Other side effects include: anxiety, blurred vision, mydriasis, tremor, vertigo, vomiting, abnormal dreams, chills, and yawning. See below for a comprehensive list of adverse effects.

For the Consumer

Applies to desvenlafaxine: oral tablet extended release

Along with its needed effects, desvenlafaxine (the active ingredient contained in Khedezla) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking desvenlafaxine:

Less common
  • Chills
  • cold sweats
  • confusion
  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
  • fast, pounding, or irregular pulse
  • headache
  • numbness or tingling in the arms or legs
  • shakiness in the legs, arms, hands, or feet
  • trouble thinking, speaking, or walking
  • weakness
Incidence not known
  • Blistering, peeling, or loosening of the skin
  • blood in the stool or urine
  • chest tightness
  • cough
  • diarrhea
  • dilated or enlarged pupils (black part of the eye)
  • feeling irritated
  • fever
  • hives, itching, or rash
  • hoarseness
  • joint pain, stiffness, or swelling
  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
  • loss of bladder control
  • muscle pain
  • muscle spasm or jerking of all extremities
  • nosebleeds
  • red skin lesions, often with a purple center
  • red, irritated eyes
  • red skin
  • seizures
  • sore throat
  • sores, ulcers, or white spots in the mouth or on the lips
  • sudden loss of consciousness
  • swelling of the eyelids, face, lips, hands, or feet
  • talking, feeling, or acting with excitement
  • trouble breathing or swallowing
  • unusual bruising
  • unusual tiredness or weakness
  • vomiting blood

Get emergency help immediately if any of the following symptoms of overdose occur while taking desvenlafaxine:

Symptoms of overdose
  • Agitation
  • bloating
  • dark urine
  • feeling of constant movement of self or surroundings
  • irregular heartbeat recurrent
  • light-colored stools
  • muscle cramp or stiffness
  • nausea
  • overactive reflexes
  • poor coordination
  • restlessness
  • seizures
  • sensation of spinning
  • shivering
  • stomach pain
  • vomiting
  • yellow eyes or skin

Some side effects of desvenlafaxine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common
  • Decreased appetite
  • inability to have an orgasm
  • inability to have or keep an erection
  • increased sensitivity of the eyes to light
  • loss of sexual ability, desire, drive, or performance
  • sleepiness or unusual drowsiness
  • sleeplessness
Less common
  • Change in taste
  • continuous ringing, buzzing, or other unexplained noise in the ears
  • decreased weight
  • difficult urination
  • fear or nervousness
  • hearing loss
  • jitteriness
  • lack or loss of strength
  • loss of taste

For Healthcare Professionals

Applies to desvenlafaxine: oral tablet extended release

General

The most commonly reported side effects were nausea, dry mouth, hyperhidrosis, and dizziness.[Ref]

Gastrointestinal

Very Common (10% or more): Nausea (up to 36%), dry mouth (up to 25%), constipation (up to 14%)
Common (1% to 10%): Diarrhea, vomiting
Rare (less than 0.1%): Acute pancreatitis
Frequency not reported: Gastrointestinal bleeding[Ref]

Dermatologic

Very Common (10% or more): Hyperhidrosis (up to 21%)
Common (1% to 10%): Rash
Uncommon (0.1% to 1%): Alopecia
Rare (less than 0.1%): Photosensitivity reaction, Stevens-Johnson syndrome
Frequency not reported: Erythema multiforme, severe cutaneous reactions, toxic epidermal necrolysis[Ref]

Nervous system

Very Common (10% or more): Dizziness (up to 16%), somnolence (up to 12%)
Common (1% to 10%): Disturbance in attention, dysgeusia, headache, paresthesia, tremor, vertigo
Uncommon (0.1% to 1%): Dyskinesia, extrapyramidal disorder, syncope
Rare (less than 0.1%): Convulsion, dystonia, serotonin syndrome
Frequency not reported: Seizure[Ref]

Psychiatric

Very common (10% or more): Insomnia (up to 15%)
Common (1% to 10%): Abnormal dreams, abnormal orgasm, anorgasmia, anxiety, decreased libido, irritability, nervousness, withdrawal syndrome
Uncommon (0.1% to 1%): Depersonalization, hypomania
Rare (less than 0.1%): Hallucination, mania
Frequency not reported: Bruxism, discontinuation syndrome, suicidal thoughts[Ref]

Genitourinary

Very Common (10% or more): Erectile dysfunction (up to 11%)
Common (1% to 10%): Delayed ejaculation, ejaculation disorder, ejaculation failure, proteinuria, sexual dysfunction, urinary hesitation
Uncommon (0.1% to 1%): Urinary retention[Ref]

Other

Very Common (10% or more): Fatigue (up to 11%)
Common (1% to 10%): Asthenia, chills, feeling jittery, tinnitus[Ref]

Metabolic

Common (1% to 10%): Decreased appetite, decreased weight, elevated fasting triglycerides, elevated LDL cholesterol, elevated total cholesterol, increased blood cholesterol, increased weight
Uncommon (0.1% to 1%): Increased blood triglycerides
Rare (less than 0.1%): Hyponatremia[Ref]

Cardiovascular

Ischemic cardiac adverse reactions, myocardial ischemia, myocardial infarction, and/or coronary occlusion requiring revascularization usually occurred in patients who had multiple underlying cardiac risk factors.[Ref]

Common (1% to 10%): Blood pressure increased, hot flush, increased sustained hypertension, orthostatic hypotension, palpitations, tachycardia
Uncommon (0.1% to 1%): Peripheral coldness
Frequency not reported: Coronary occlusion requiring revascularization, ischemic cardiac adverse reactions, myocardial infarction, myocardial ischemia[Ref]

Ocular

Common (1% to 10%): Blurred vision, mydriasis
Frequency not reported: Angle closure glaucoma[Ref]

Respiratory

Common (1% to 10%): Yawning
Uncommon (0.1% to 1%): Epistaxis
Frequency not reported: Interstitial lung disease, eosinophilic pneumonia[Ref]

Hepatic

Common (1% to 10%): Abnormal liver function test[Ref]

Musculoskeletal

Common (1% to 10%): Musculoskeletal stiffness[Ref]

Hypersensitivity

Uncommon (0.1% to 1%): Hypersensitivity
Rare (less than 0.1%): Angioedema[Ref]

Endocrine

Uncommon (0.1% to 1%): Increased blood prolactin[Ref]

Hematologic

Frequency not reported: Abnormal bleeding[Ref]

References

1. "Product Information. Pristiq (desvenlafaxine)." Wyeth Laboratories, Philadelphia, PA.

2. Cerner Multum, Inc. "Australian Product Information." O 0

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Hide